Four-Drug Combo for HCV Shows Early Promise - MedPage Today

[INCIID News Feed]

<img alt="" height="1" width="1" />
Four-Drug Combo for HCV Shows Early Promise
MedPage Today
Combining traditional therapy for hepatitis C virus (HCV) infection with the newly approved drug telaprevir (Incivek) and an investigational oral HCV polymerase inhibitor boosted 24-week complete virologic ...
Vertex reports swift success with combo hep C treatmentFierceBiotech
Vertex drug combo shows progress on hepatitis CMass High Tech
Interim Data from Phase 2 Study of Combination Regimen Including VX-222 and ...Financial Post

all 19 news articles &raquo;


More...